Volume 12; Issue supp-S3

European Neuropsychopharmacology

Volume 12; Issue supp-S3
2

Opioids and the dynamics of addiction

Year:
2002
Language:
english
File:
PDF, 268 KB
english, 2002
3

Driving forces in brain research

Year:
2002
Language:
english
File:
PDF, 200 KB
english, 2002
4

Can we identify an early target population in high risk studies?

Year:
2002
Language:
english
File:
PDF, 115 KB
english, 2002
5

Prodromal psychotic states and their treatment

Year:
2002
Language:
english
File:
PDF, 242 KB
english, 2002
6

Do biological findings help to identify a risk group?

Year:
2002
Language:
english
File:
PDF, 129 KB
english, 2002
7

Atypical neuroleptics in prevention of relapse in schizophrenia

Year:
2002
Language:
english
File:
PDF, 129 KB
english, 2002
8

What provokes the onset of psychosis?

Year:
2002
Language:
english
File:
PDF, 133 KB
english, 2002
9

Patients in depression trials

Year:
2002
Language:
english
File:
PDF, 127 KB
english, 2002
10

Criteria for efficacy of clinical trials in depression

Year:
2002
Language:
english
File:
PDF, 258 KB
english, 2002
11

The nicotinic receptors in the human brain

Year:
2002
Language:
english
File:
PDF, 266 KB
english, 2002
12

Effects of nicotine on the mesolimbic dopaminergic reward system in brain

Year:
2002
Language:
english
File:
PDF, 133 KB
english, 2002
13

Clinical symptomatology of nicotine withdrawal, and its control, in humans

Year:
2002
Language:
english
File:
PDF, 262 KB
english, 2002
14

Chronic nicotine treatment and nicotinic receptor function

Year:
2002
Language:
english
File:
PDF, 268 KB
english, 2002
17

The role of the endogenous hippocampal opioid system in spatial learning

Year:
2002
Language:
english
File:
PDF, 125 KB
english, 2002
23

Lithium and the treatment of mania

Year:
2002
Language:
english
File:
PDF, 133 KB
english, 2002
24

Typical and atypical antipsychotics in the treatment of mania

Year:
2002
Language:
english
File:
PDF, 135 KB
english, 2002
25

Recent maintenance research in bipolar I disorder

Year:
2002
Language:
english
File:
PDF, 268 KB
english, 2002
26

Treatment of rapid cycling bipolar disorder

Year:
2002
Language:
english
File:
PDF, 267 KB
english, 2002
27

Brain imaging studies on the mechanism of action of mood stabilisers

Year:
2002
Language:
english
File:
PDF, 132 KB
english, 2002
31

The inflammatory hypothesis of Alzheimer's disease: Where do we stand?

Year:
2002
Language:
english
File:
PDF, 269 KB
english, 2002
32

Vascular problems in Alzheimer's disease

Year:
2002
Language:
english
File:
PDF, 278 KB
english, 2002
34

Neurosteroids: Functional aspects

Year:
2002
Language:
english
File:
PDF, 277 KB
english, 2002
36

Perspective on NO in brain function

Year:
2002
Language:
english
File:
PDF, 132 KB
english, 2002
38

In vivo studies of glutamatergic receptors and NO pathways in brain

Year:
2002
Language:
english
File:
PDF, 271 KB
english, 2002
39

Stress and brain nitric oxide

Year:
2002
Language:
english
File:
PDF, 277 KB
english, 2002
40

NMDA receptors and NO signalling in cerebellar synaptic plasticity

Year:
2002
Language:
english
File:
PDF, 267 KB
english, 2002
41

Different efficacy of antidepressants in inpatients with depression

Year:
2002
Language:
english
File:
PDF, 131 KB
english, 2002
42

Resistant depression: Patterns of treatment response

Year:
2002
Language:
english
File:
PDF, 138 KB
english, 2002
43

Safety and efficacy of antidepressants in older people

Year:
2002
Language:
english
File:
PDF, 264 KB
english, 2002
44

Depression and anhedonia in Parkinson's disease

Year:
2002
Language:
english
File:
PDF, 128 KB
english, 2002
45

Cognitive deterioration in Parkinson's disease

Year:
2002
Language:
english
File:
PDF, 264 KB
english, 2002
46

Brain stimulation and the modulation of emotions in Parkinson's disease

Year:
2002
Language:
english
File:
PDF, 273 KB
english, 2002
50

Sensitization in the pathogenesis and natural history of schizophrenia

Year:
2002
Language:
english
File:
PDF, 130 KB
english, 2002
51

Brain-derived neurotrophic factor, dopamine receptors and behavioral sensitization

Year:
2002
Language:
english
File:
PDF, 130 KB
english, 2002
53

Control of neurotransmitter release by metabotropic glutamate receptors

Year:
2002
Language:
english
File:
PDF, 269 KB
english, 2002
54

Anatomy, physiology and pharmacology of GABAB receptors

Year:
2002
Language:
english
File:
PDF, 270 KB
english, 2002
56

Inverse agonism at D2 dopamine receptors — Relevance to antipsychotic action

Year:
2002
Language:
english
File:
PDF, 256 KB
english, 2002
57

Low versus high doses of methadone

Year:
2002
Language:
english
File:
PDF, 261 KB
english, 2002
58

Evidence-based treatment with buprenorphine

Year:
2002
Language:
english
File:
PDF, 268 KB
english, 2002
59

Beneficial effect of heroin in heroin addicts

Year:
2002
Language:
english
File:
PDF, 133 KB
english, 2002
61

The ideal treatment of withdrawal

Year:
2002
Language:
english
File:
PDF, 390 KB
english, 2002
62

Gender and gonadal steroids: Influence on HPA activity and emotional neuroactivity

Year:
2002
Language:
english
File:
PDF, 272 KB
english, 2002
64

Mood disorders and sexual dimorphism in neurotransmitter systems

Year:
2002
Language:
english
File:
PDF, 272 KB
english, 2002
65

Maternal depression and child psychopathology

Year:
2002
Language:
english
File:
PDF, 274 KB
english, 2002
66

Mood and the menstrual cycle: Phenomenology and novel treatments

Year:
2002
Language:
english
File:
PDF, 272 KB
english, 2002
67

Cannabinoid receptors and their ligands

Year:
2002
Language:
english
File:
PDF, 262 KB
english, 2002
68

Endogenous cannabinoids and brain development

Year:
2002
Language:
english
File:
PDF, 127 KB
english, 2002
69

Behavioral pharmacology of cannabinoids in animals

Year:
2002
Language:
english
File:
PDF, 135 KB
english, 2002
70

Endogenous acylethanolamides modulates pain perception in mice

Year:
2002
Language:
english
File:
PDF, 131 KB
english, 2002
71

Cannabinoid effects on neurocognition: Implications for psychosis

Year:
2002
Language:
english
File:
PDF, 254 KB
english, 2002
76

Regulatory issues in severe dementia

Year:
2002
Language:
english
File:
PDF, 276 KB
english, 2002
77

Cognition changes in placebo controlled trials in severe dementia

Year:
2002
Language:
english
File:
PDF, 261 KB
english, 2002
78

Long-term treatment with memantine in advanced AD

Year:
2002
Language:
english
File:
PDF, 120 KB
english, 2002
79

Therapy of Alzheimer's disease reducing beta-A: Now and the future

Year:
2002
Language:
english
File:
PDF, 120 KB
english, 2002
80

Atypical antipsychotics in behavioral disturbances in Alzheimer's disease

Year:
2002
Language:
english
File:
PDF, 127 KB
english, 2002
81

Imaging GABAA receptor subtypes with PET

Year:
2002
Language:
english
File:
PDF, 257 KB
english, 2002
83

Brain spect in drug research and development (DRD): Recent advances

Year:
2002
Language:
english
File:
PDF, 268 KB
english, 2002
84

Augmentation strategies: 5-HT and beyond

Year:
2002
Language:
english
File:
PDF, 132 KB
english, 2002
85

The place of peptide systems in major depression and anxiety

Year:
2002
Language:
english
File:
PDF, 266 KB
english, 2002
86

Neurotrophic actions of antidepressants

Year:
2002
Language:
english
File:
PDF, 135 KB
english, 2002
87

Galanin: New opportunities for antidepressant drug development

Year:
2002
Language:
english
File:
PDF, 267 KB
english, 2002
89

Neurotrophic factors and brain ischemia

Year:
2002
Language:
english
File:
PDF, 132 KB
english, 2002
91

Preclinical and clinical overview of nemifitide, a novel antidepressant

Year:
2002
Language:
english
File:
PDF, 270 KB
english, 2002
93

Imaging studies on negative symptoms in schizophrenia

Year:
2002
Language:
english
File:
PDF, 265 KB
english, 2002
94

Depression, anxiety, and suicide in schizophrenia

Year:
2002
Language:
english
File:
PDF, 256 KB
english, 2002
95

Efficacy of new antipsychotics on cognitive functions in schizophrenia

Year:
2002
Language:
english
File:
PDF, 122 KB
english, 2002
96

Patterns of familial aggregation of anxiety and depressive disorders in the community

Year:
2002
Language:
english
File:
PDF, 122 KB
english, 2002
98

The burden of anxiety and depressive disorders: The ESEMeD study

Year:
2002
Language:
english
File:
PDF, 131 KB
english, 2002
99

Preliminary results of the ESEMeD/MHEDEA 2000 study

Year:
2002
Language:
english
File:
PDF, 257 KB
english, 2002
100

The interplay of distal and proximal risk factors in the aetiology of depression and anxiety

Year:
2002
Language:
english
File:
PDF, 128 KB
english, 2002
101

Neurotransmitters, genetic models and anxiety

Year:
2002
Language:
english
File:
PDF, 266 KB
english, 2002
104

Melanocortin system and eating disorders

Year:
2002
Language:
english
File:
PDF, 267 KB
english, 2002
105

The role of GABA-A receptors subtypes in the effects of benzodiazepines

Year:
2002
Language:
english
File:
PDF, 260 KB
english, 2002
107

Prevalence and cost of anxiety disorders in the new century

Year:
2002
Language:
english
File:
PDF, 261 KB
english, 2002
109

Treatment and outcome of post-traumatic stress disorder

Year:
2002
Language:
english
File:
PDF, 260 KB
english, 2002
110

The new management of GAD

Year:
2002
Language:
english
File:
PDF, 132 KB
english, 2002
111

How long to treat anxiety disorders?

Year:
2002
Language:
english
File:
PDF, 262 KB
english, 2002
112

Antisuicidal effect of lithium

Year:
2002
Language:
english
File:
PDF, 263 KB
english, 2002
113

Do antidepressants reduce mortality in unipolar patients?

Year:
2002
Language:
english
File:
PDF, 133 KB
english, 2002
114

Antidepressants and mortality in depressed patients with concomitant illness

Year:
2002
Language:
english
File:
PDF, 264 KB
english, 2002
115

Do atypical neuroleptics reduce mortality among patients with schizophrenia?

Year:
2002
Language:
english
File:
PDF, 128 KB
english, 2002
116

Chemical neuroanatomy of the prefrontal cortex

Year:
2002
Language:
english
File:
PDF, 265 KB
english, 2002
118

Dopamine D3 receptors: Functional significance and novel ligands as antipsychotic agents

Year:
2002
Language:
english
File:
PDF, 271 KB
english, 2002
119

Modulation of the activity of prefrontal circuits by 5-HT2A/5-HT1A receptors

Year:
2002
Language:
english
File:
PDF, 266 KB
english, 2002
121

Anti-depressant therapy: Identification of novel targets

Year:
2002
Language:
english
File:
PDF, 135 KB
english, 2002
122

A critical appraisal of antidepressant drug development

Year:
2002
Language:
english
File:
PDF, 269 KB
english, 2002
124

Glutamatergic mechanisms in antidepressant treatments

Year:
2002
Language:
english
File:
PDF, 176 KB
english, 2002
125

Depression at adolescence

Year:
2002
Language:
english
File:
PDF, 106 KB
english, 2002
126

Adolescents' depression: A trouble of internality?

Year:
2002
Language:
english
File:
PDF, 106 KB
english, 2002
128

Steroid receptor inhibition by targeting heat shock protein 90

Year:
2002
Language:
english
File:
PDF, 122 KB
english, 2002
131

Family study of recurrent depressive disorder in the patients with schizotypal disorder

Year:
2002
Language:
english
File:
PDF, 126 KB
english, 2002
132

Predictors of improvement: Switching from daily SSRIs to fluoxetine once-weekly

Year:
2002
Language:
english
File:
PDF, 244 KB
english, 2002
133

Long-term safety upon switching from daily SSRIs to fluoxetine once-weekly

Year:
2002
Language:
english
File:
PDF, 119 KB
english, 2002
139

The prevalence of general anxiety disorder in the primary care population

Year:
2002
Language:
english
File:
PDF, 122 KB
english, 2002
149

Impact of racing thoughts on depression

Year:
2002
Language:
english
File:
PDF, 127 KB
english, 2002
150

Mood reactivity and atypical depression

Year:
2002
Language:
english
File:
PDF, 129 KB
english, 2002
154

Effect of E-6006 citrate upon schedule-induced polydipsia (SIP)

Year:
2002
Language:
english
File:
PDF, 245 KB
english, 2002
168

Mental disorders in the first degree relatives of bipolar patients

Year:
2002
Language:
english
File:
PDF, 125 KB
english, 2002
169

Cosegregation of schizophrenia and bipolar disorder in a family

Year:
2002
Language:
english
File:
PDF, 249 KB
english, 2002
172

Bone mineral density in female depressive patients

Year:
2002
Language:
english
File:
PDF, 128 KB
english, 2002
185

Tolerability of single versus split daily dosing of antidepressants: A meta-analysis

Year:
2002
Language:
english
File:
PDF, 252 KB
english, 2002
191

Premenstrual symptom changes among women with mood disorders

Year:
2002
Language:
english
File:
PDF, 241 KB
english, 2002
196

MAO-A gene functional polymorphism in major depressive disorder

Year:
2002
Language:
english
File:
PDF, 109 KB
english, 2002
197

Using sleep to measure relative 5HT uptake blockade

Year:
2002
Language:
english
File:
PDF, 109 KB
english, 2002
206

Escitalopram in the treatment of severe depression

Year:
2002
Language:
english
File:
PDF, 123 KB
english, 2002
208

Reboxetine vs venlafaxine in the treatment of severe major depression

Year:
2002
Language:
english
File:
PDF, 249 KB
english, 2002
209

Reboxetine and sexual side effects

Year:
2002
Language:
english
File:
PDF, 127 KB
english, 2002
212

Reboxetine effects on cognitive functioning in depressed patients

Year:
2002
Language:
english
File:
PDF, 116 KB
english, 2002
214

Inadequate treatment of depression in general hospital

Year:
2002
Language:
english
File:
PDF, 130 KB
english, 2002
215

Economics of high dose venlafaxine in depressed patients

Year:
2002
Language:
english
File:
PDF, 235 KB
english, 2002
224

Modafinil as augmentation of antidepressant therapy

Year:
2002
Language:
english
File:
PDF, 247 KB
english, 2002
225

Discontinuation of valproate in BP maintenance: One-year follow-up

Year:
2002
Language:
english
File:
PDF, 131 KB
english, 2002
228

The antidepressant duloxetine reduces anxiety symptom severity

Year:
2002
Language:
english
File:
PDF, 123 KB
english, 2002
232

Duloxetine 60 mg QD is efficacious in the treatment of depression

Year:
2002
Language:
english
File:
PDF, 123 KB
english, 2002
241

Prevalence of bipolar spectrum in US adults

Year:
2002
Language:
english
File:
PDF, 123 KB
english, 2002
243

Long-term synaptic plasticity: A novel pathophysiological model for affective disorders

Year:
2002
Language:
english
File:
PDF, 241 KB
english, 2002
247

Early VEP abnormalities in depressed patients

Year:
2002
Language:
english
File:
PDF, 243 KB
english, 2002
248

Antipsychotic compliance evaluation

Year:
2002
Language:
english
File:
PDF, 126 KB
english, 2002
252

Longitudinal course of pediatric-onset bipolar disorder

Year:
2002
Language:
english
File:
PDF, 127 KB
english, 2002
264

A meta analsis of the core features of pediatric bipolar disorder

Year:
2002
Language:
english
File:
PDF, 253 KB
english, 2002
265

Serotonin transporter polymorphism and long-term effect of antidepressant treatment

Year:
2002
Language:
english
File:
PDF, 129 KB
english, 2002
267

Efficacy of venlafaxine on a derived self-rating scale of well being

Year:
2002
Language:
english
File:
PDF, 128 KB
english, 2002
275

Escitalopram offers early separation from placebo in the treatment of depression

Year:
2002
Language:
english
File:
PDF, 126 KB
english, 2002
277

Remission rates in elderly depressed patients treated with sertraline

Year:
2002
Language:
english
File:
PDF, 125 KB
english, 2002
278

Symptom pattern analysis of premenstrual dysphoric disorder (PMDD)

Year:
2002
Language:
english
File:
PDF, 125 KB
english, 2002
281

Onset of action of Mirtazapine: A review of comparative studies

Year:
2002
Language:
english
File:
PDF, 258 KB
english, 2002
289

Remission after long-term treatment with venlafaxine

Year:
2002
Language:
english
File:
PDF, 241 KB
english, 2002
290

Remission based on HAM-D subscales

Year:
2002
Language:
english
File:
PDF, 114 KB
english, 2002
294

Topiramate as a mood stabilizer for epilepsy comorbid with mood disorders

Year:
2002
Language:
english
File:
PDF, 126 KB
english, 2002
295

IDN 5491 (Hyperforin trimethoxybenzoate): A new antidepressive drug

Year:
2002
Language:
english
File:
PDF, 121 KB
english, 2002
296

Successful treatment of reboxetine-associated urinary hesitancy with tamsulosin

Year:
2002
Language:
english
File:
PDF, 121 KB
english, 2002
330

Incidence of schizofrenia in Surinam: Selective immigration?

Year:
2002
Language:
english
File:
PDF, 111 KB
english, 2002
334

Plasma homocysteine in schizophrenia

Year:
2002
Language:
english
File:
PDF, 249 KB
english, 2002
336

A factor structure of methamphetamine psychotic symptoms

Year:
2002
Language:
english
File:
PDF, 257 KB
english, 2002
339

Reasons for discontinuation of clozapine

Year:
2002
Language:
english
File:
PDF, 128 KB
english, 2002
350

Weight gain during psychiatric inpatient treatment

Year:
2002
Language:
english
File:
PDF, 122 KB
english, 2002
360

Sleep quality in schizophrenic patients and the effects of antipsychotic medication

Year:
2002
Language:
english
File:
PDF, 129 KB
english, 2002
374

Anticipation in schizophrenia: The results of multiple regression analysis

Year:
2002
Language:
english
File:
PDF, 129 KB
english, 2002
379

Relationship between quetiapine dose and efficacy

Year:
2002
Language:
english
File:
PDF, 125 KB
english, 2002
385

Anticipation: One latent dimension of the schizophrenic disorder

Year:
2002
Language:
english
File:
PDF, 248 KB
english, 2002
392

Effects of intra-accumbal injection of dopamine D3 ligands on rat behaviour

Year:
2002
Language:
english
File:
PDF, 129 KB
english, 2002
397

Olanzapine treatment of the depressive symptoms in schizophrenia

Year:
2002
Language:
english
File:
PDF, 125 KB
english, 2002
399

Antipsychotic treatment of geropsychiatric inpatients

Year:
2002
Language:
english
File:
PDF, 119 KB
english, 2002
405

Safety and tolerability of aripiprazole at doses higher than 30 mg

Year:
2002
Language:
english
File:
PDF, 119 KB
english, 2002
407

Aripiprazole versus placebo in acute mania

Year:
2002
Language:
english
File:
PDF, 129 KB
english, 2002
410

Meta-analysis of weight effects with aripiprazole

Year:
2002
Language:
english
File:
PDF, 123 KB
english, 2002
411

Aripiprazole: A dopamine-serotonin system stabilizer

Year:
2002
Language:
english
File:
PDF, 244 KB
english, 2002
413

Sequential IM/oral ziprasidone vs haloperidol in severe schizophrenia

Year:
2002
Language:
english
File:
PDF, 122 KB
english, 2002
416

The schizophrenia clinical trial consortium for modeling placebo response

Year:
2002
Language:
english
File:
PDF, 121 KB
english, 2002
417

Switching to aripiprazole monotherapy

Year:
2002
Language:
english
File:
PDF, 235 KB
english, 2002
419

Ziprasidone vs olanzapine for cognitive function in schizophrenia

Year:
2002
Language:
english
File:
PDF, 117 KB
english, 2002
422

Safety and tolerability of IM ziprasidone: Review of clinical trial data

Year:
2002
Language:
english
File:
PDF, 127 KB
english, 2002
428

The cognitive effects of conventional and atypical antipsychotics in schizophrenia

Year:
2002
Language:
english
File:
PDF, 129 KB
english, 2002
432

Fos-like immunoreactivity in rat brain induced by cytokine administration

Year:
2002
Language:
english
File:
PDF, 110 KB
english, 2002
437

Prolactic serum levels after long term risperidone treatment

Year:
2002
Language:
english
File:
PDF, 132 KB
english, 2002
443

Antipsychotic agents and serum creatine kinase levels

Year:
2002
Language:
english
File:
PDF, 118 KB
english, 2002
455

Effect of conventional and atypical antipsychotics on neurogenesis in rats

Year:
2002
Language:
english
File:
PDF, 128 KB
english, 2002
465

Ziprasidone vs amisulpride for negative symptoms of schizophrenia

Year:
2002
Language:
english
File:
PDF, 121 KB
english, 2002
469

Anticholinergic effect of atypical antipsychotics in elderly patients

Year:
2002
Language:
english
File:
PDF, 127 KB
english, 2002
472

Effect of smoking status on olanzapine-induced weight gain

Year:
2002
Language:
english
File:
PDF, 122 KB
english, 2002
473

Improvement of insulin indices after switch from olanzapine to risperidone

Year:
2002
Language:
english
File:
PDF, 122 KB
english, 2002
474

Sexual dysfunction and adherence to antipsychotic therapy in schizophrenia

Year:
2002
Language:
english
File:
PDF, 243 KB
english, 2002
489

Prolactin and Risperidone in the current clinical practice: Results

Year:
2002
Language:
english
File:
PDF, 120 KB
english, 2002
499

Acute and chronic drug-induced akathisia: A clinical comparison

Year:
2002
Language:
english
File:
PDF, 241 KB
english, 2002
501

Risperidone treatment of patients with chronic schizophrenia in a primary care setting

Year:
2002
Language:
english
File:
PDF, 131 KB
english, 2002
503

Quetiapine in the treatment of borderline personality disorder

Year:
2002
Language:
english
File:
PDF, 127 KB
english, 2002
504

Therapeutic drug-monitoring of Amisulpride in schizophrenic patients

Year:
2002
Language:
english
File:
PDF, 127 KB
english, 2002
509

Shyness and the serotonin transporter promoter

Year:
2002
Language:
english
File:
PDF, 246 KB
english, 2002
514

CRF mediates conditioned anxiety to nicotine

Year:
2002
Language:
english
File:
PDF, 121 KB
english, 2002
523

Characteristics of benzodiazepine users in a high-security Greek prison

Year:
2002
Language:
english
File:
PDF, 130 KB
english, 2002
529

Citalopram challenge in social anxiety disorder

Year:
2002
Language:
english
File:
PDF, 250 KB
english, 2002
533

Poster Session

Year:
2002
Language:
english
File:
PDF, 124 KB
english, 2002
537

High dose sertraline strategy in OCD acute treatment non-responders

Year:
2002
Language:
english
File:
PDF, 124 KB
english, 2002
539

Efficacy and tolerability of escitalopram in the treatment of anxiety disorders

Year:
2002
Language:
english
File:
PDF, 126 KB
english, 2002
544

Health care costs among managed care enrollees with anxiety disorders

Year:
2002
Language:
english
File:
PDF, 128 KB
english, 2002
547

Paroxetine in social anxiety disorder: A remission analysis

Year:
2002
Language:
english
File:
PDF, 253 KB
english, 2002
551

Remission analysis of patients with panic disorder treated with paroxetine

Year:
2002
Language:
english
File:
PDF, 253 KB
english, 2002
554

Cortisol secretion in healthy volunteers after 35% CO2 inhalation

Year:
2002
Language:
english
File:
PDF, 128 KB
english, 2002
565

Quality of life in anxiety and depressive disorders

Year:
2002
Language:
english
File:
PDF, 129 KB
english, 2002
570

Treating social anxiety disorder with venlafaxine extended release

Year:
2002
Language:
english
File:
PDF, 117 KB
english, 2002
573

Reduced sensitivity to temazepam in panic disorder

Year:
2002
Language:
english
File:
PDF, 124 KB
english, 2002
581

Comorbidity in obsessive-compulsive disorder

Year:
2002
Language:
english
File:
PDF, 117 KB
english, 2002
588

Influence of hypoosmotic incubation medium on neurotransmitter uptake in rat brain

Year:
2002
Language:
english
File:
PDF, 125 KB
english, 2002
591

Olanzapine for Huntington's disease: An open label study

Year:
2002
Language:
english
File:
PDF, 123 KB
english, 2002
592

Neuroprotection in Huntington's disease: Minocycline

Year:
2002
Language:
english
File:
PDF, 245 KB
english, 2002
603

Ascorbate recycling causes brain damages by oxidative stress

Year:
2002
Language:
english
File:
PDF, 131 KB
english, 2002
605

Predicting response to rivastigmine in dementia with Lewy Bodies

Year:
2002
Language:
english
File:
PDF, 117 KB
english, 2002
607

The efficacy of donezepil in Alzheimer's disease cognitive deficit

Year:
2002
Language:
english
File:
PDF, 128 KB
english, 2002
612

Gabapentin in the treatment of non-cognitive symptoms of dementia

Year:
2002
Language:
english
File:
PDF, 123 KB
english, 2002
616

Ascorbic acid inhibits prostaglandin E2 release in primary rat microglia

Year:
2002
Language:
english
File:
PDF, 123 KB
english, 2002
618

Galantamine for Parkinson's disease with dementia

Year:
2002
Language:
english
File:
PDF, 247 KB
english, 2002
624

Respiratory chain enzyme activity and iron metabolism dysfunction in Parkinsonism

Year:
2002
Language:
english
File:
PDF, 120 KB
english, 2002
625

Effects of methylphenidate on attention in closed head injury

Year:
2002
Language:
english
File:
PDF, 243 KB
english, 2002
626

CSF hypocretin levels in Korean narcoleptic patients

Year:
2002
Language:
english
File:
PDF, 125 KB
english, 2002
631

Depression and Parkinson's disease

Year:
2002
Language:
english
File:
PDF, 128 KB
english, 2002
633

Dopamine dysfunction in smokers is related to degree of nicotine dependence

Year:
2002
Language:
english
File:
PDF, 124 KB
english, 2002
636

COMT gene polymorphism in alcohol dependence

Year:
2002
Language:
english
File:
PDF, 123 KB
english, 2002
637

The effect of papaverine on the acute opiate withdrawal in guinea pig ileum

Year:
2002
Language:
english
File:
PDF, 123 KB
english, 2002
640

Norharman and alcohol-dependency in male wistar rats

Year:
2002
Language:
english
File:
PDF, 254 KB
english, 2002
647

Antisocial personality disorder-heroin-dependence comorbidity

Year:
2002
Language:
english
File:
PDF, 124 KB
english, 2002
650

EuropaASI and opioid dependence pharmaceutical treatment

Year:
2002
Language:
english
File:
PDF, 118 KB
english, 2002
654

Effects of naltrexone on subjective acute alcohol effects in social drinkers

Year:
2002
Language:
english
File:
PDF, 129 KB
english, 2002
677

The association of DRD4 and 5-HTTLPR with infant temperament

Year:
2002
Language:
english
File:
PDF, 134 KB
english, 2002
683

Neuropeptide semax — Effective antithrombotic drug

Year:
2002
Language:
english
File:
PDF, 237 KB
english, 2002
685

Effects of gemfibrozil on mood and neurocognitive functions in normal adults

Year:
2002
Language:
english
File:
PDF, 121 KB
english, 2002
689

Hippocampal nociceptin system and spatial learning in mice

Year:
2002
Language:
english
File:
PDF, 128 KB
english, 2002
690

5-HT1A receptors in septal GABAergic and cholinergic neurons

Year:
2002
Language:
english
File:
PDF, 250 KB
english, 2002
692

Discriminative properties of various NMDA receptor antagonists in PCP-trained rats

Year:
2002
Language:
english
File:
PDF, 123 KB
english, 2002
695

Citalopram for compulsive shopping disorder: A double-blind study

Year:
2002
Language:
english
File:
PDF, 242 KB
english, 2002
714

ADHD has a significant burden upon the individual, family, and society in Europe

Year:
2002
Language:
english
File:
PDF, 130 KB
english, 2002
716

Venlafaxine in attention deficit hyperactivity disorder

Year:
2002
Language:
english
File:
PDF, 111 KB
english, 2002
721

Quetiapine in Tourette's disorder

Year:
2002
Language:
english
File:
PDF, 115 KB
english, 2002
723

Risperidone in children and adolescents with conduct disorder

Year:
2002
Language:
english
File:
PDF, 123 KB
english, 2002
724

Effects of chronic treatment of ondansetron, on pentylenetetrazole-induced seizures

Year:
2002
Language:
english
File:
PDF, 123 KB
english, 2002
730

Neurological soft signs in schizo-obsessive patients

Year:
2002
Language:
english
File:
PDF, 128 KB
english, 2002
731

Hypnotizability, pain threshold and dissociative experiences

Year:
2002
Language:
english
File:
PDF, 253 KB
english, 2002
733

Milnacipran in the treatment of bulimia: A report of 16 cases

Year:
2002
Language:
english
File:
PDF, 246 KB
english, 2002
734

Gene therapy administrated intracisternally using liposome vector for cerebral vasospasm

Year:
2002
Language:
english
File:
PDF, 122 KB
english, 2002
740

Dyspepsia in chronic psychiatric patients

Year:
2002
Language:
english
File:
PDF, 249 KB
english, 2002
747

Thyroid functions in lithium-treated patients

Year:
2002
Language:
english
File:
PDF, 128 KB
english, 2002
755

Nondominant hemisphere dysfunction in Asperger's disorder

Year:
2002
Language:
english
File:
PDF, 112 KB
english, 2002
756

Author index

Year:
2002
File:
PDF, 1.39 MB
2002
757

Keyword index

Year:
2002
Language:
english
File:
PDF, 571 KB
english, 2002
758

16th ECNP Congress

Year:
2002
Language:
english
File:
PDF, 48 KB
english, 2002
760

4th ECNP workshop neuropsychopharmacology of addiction

Year:
2002
File:
PDF, 34 KB
2002
761

Calendar of events

Year:
2002
Language:
english
File:
PDF, 50 KB
english, 2002